Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Node colors represent genes associated with different symptoms.The GO BP of overlapping genes enriched of insomnia-fever-rash cluster.IDGO_BPP-value (P < 0.01)1Immune response2.70E-122Adaptive immune response7.90E-073B-cell receptor signaling pathway5.80E-064B-cell differentiation1.30E-055T-cell receptor signaling pathway1.70E-056Interferon-gamma-mediated signaling pathway1.70E-057Positive regulation of gene expression2.10E-058Positive regulation of nitric oxide biosynthetic process1.10E-049Platelet activation1.20E-0410Growth hormone receptor signaling pathway1.30E-0411Negative regulation of lipid storage1.30E-0412Intrinsic apoptotic signaling pathway in response to DNA damage1.50E-0413Cytokine-mediated signaling pathway1.90E-0414Positive regulation of transcription from RNA polymerase II promoter2.20E-0415Antigen processing and presentation2.40E-0416Humoral immune response2.70E-0417Negative regulation of apoptotic process4.40E-0418JAK-STAT cascade involved in growth hormone signaling pathway4.90E-0419T-cell costimulation6.70E-0420Blood coagulation6.90E-0421Defense response to protozoan7.90E-0422Inflammatory response1.40E-0323Positive regulation of sequence-specific DNA binding transcription factor activity1.60E-0324Cellular response to lipopolysaccharide2.00E-0325Tumor necrosis factor-mediated signaling pathway2.20E-0326Positive regulation of NF-kappaB transcription factor activity3.10E-0327Positive regulation of tyrosine phosphorylation of Stat3 protein3.20E-0328Extrinsic apoptotic signaling pathway via death domain receptors3.20E-0329Acute-phase response3.30E-0330Positive regulation of B-cell proliferation3.30E-0331Negative regulation of gene expression3.40E-0332Extrinsic apoptotic signaling pathway3.80E-0333Defense response to bacterium4.00E-0334Viral process4.10E-0335Positive regulation of vitamin D biosynthetic process4.40E-0336Positive regulation of growth factor dependent skeletal muscle satellite cell proliferation4.40E-0337Positive regulation of interferon-gamma production4.60E-0338Positive regulation of tumor necrosis factor production4.80E-0339Positive regulation of transcription, DNA-templated5.20E-0340Neutrophil apoptotic process6.60E-0341Positive regulation of calcidiol 1-monooxygenase activity6.60E-0342Positive regulation of ERK1 and ERK2 cascade6.70E-0343Positive regulation of T cell proliferation7.70E-0344I-kappaB kinase/NF-kappaB signaling7.70E-0345Regulation of cell proliferation7.80E-03To measure the function of overlapping genes in PPI network of insomnia-fever-rash cluster, we obtained the specific gene ontology function categories terms in biological process (GO_BP) of 38 overlapping genes (including the overlapping genes for two symptoms) for the cluster (P-value < 0.01).
Source: Case study: insomnia symptom clusters. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Diversity and molecular network patterns of symptom phenotypes
Study design awaiting verification · NPJ Systems Biology and Applications · 2021
Original publication title
Diversity and molecular network patterns of symptom phenotypes
© The Author(s) 2021
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
What does the authors’ abstract report?
Symptom phenotypes have continuously been an important clinical entity for clinical diagnosis and management. However, non-specificity of symptom phenotypes for clinical diagnosis is one of the major challenges that need be addressed to advance symptom science and precision health. Network medicine has delivered a successful approach for understanding the underlying mechanisms of complex disease phenotypes, which will also be a useful tool for symptom science. Here, we extracted symptom co-occurrences from clinical textbooks to construct phenotype network of symptoms with clinical co-occurrence and incorporated high-quality symptom-gene associations and protein: protein interactions to explore the molecular network patterns of symptom phenotypes.
Furthermore, we adopted established network diversity measure in network medicine to quantify both the phenotypic diversity (i.e., non-specificity) and molecular diversity of symptom phenotypes. The results showed that the clinical diversity of symptom phenotypes could partially be explained by their underlying molecular network diversity (PCC = 0.49, P-value = 2.14E-08). For example, non-specific symptoms, such as chill, vomiting, and amnesia, have both high phenotypic and molecular network diversities. Moreover, we further validated and confirmed the approach of symptom clusters to reduce the non-specificity of symptom phenotypes.
Network diversity proposes a useful approach to evaluate the non-specificity of symptom phenotypes and would help elucidate the underlying molecular network mechanisms of symptom phenotypes and thus promotes the advance of symptom science for precision health.
Authors’ abstract
Symptom phenotypes have continuously been an important clinical entity for clinical diagnosis and management. However, non-specificity of symptom phenotypes for clinical diagnosis is one of the major challenges that need be addressed to advance symptom science and precision health. Network medicine has delivered a successful approach for understanding the underlying mechanisms of complex disease phenotypes, which will also be a useful tool for symptom science. Here, we extracted symptom co-occurrences from clinical textbooks to construct phenotype network of symptoms with clinical co-occurrence and incorporated high-quality symptom-gene associations and protein: protein interactions to explore the molecular network patterns of symptom phenotypes.
Furthermore, we adopted established network diversity measure in network medicine to quantify both the phenotypic diversity (i.e., non-specificity) and molecular diversity of symptom phenotypes. The results showed that the clinical diversity of symptom phenotypes could partially be explained by their underlying molecular network diversity (PCC = 0.49, P-value = 2.14E-08). For example, non-specific symptoms, such as chill, vomiting, and amnesia, have both high phenotypic and molecular network diversities. Moreover, we further validated and confirmed the approach of symptom clusters to reduce the non-specificity of symptom phenotypes.
Network diversity proposes a useful approach to evaluate the non-specificity of symptom phenotypes and would help elucidate the underlying molecular network mechanisms of symptom phenotypes and thus promotes the advance of symptom science for precision health.
Publication and source details
Original title: Diversity and molecular network patterns of symptom phenotypes
Zixin Shu; Jingjing Wang; Hailong Sun; Ning Xu; Chenxia Lu; Runshun Zhang; Xiaodong Li; Baoyan Liu; Xuezhong Zhou
NPJ Systems Biology and Applications · 2021
© The Author(s) 2021https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.This work is partially supported by the National Key Research and Development Program (Nos. 2017YFC1703506, 2017YFC1703505, 2017YFC1703502, 2020YFC0841600 and 2020YFC0845000-4), the Natural Science Foundation of Beijing (Nos. M21012), the Fundamental Research Funds for the Central Public Welfare Research Institutes (Nos. ZZ10-005 and 2018JBZ006), the National Major Scientific and Technological Special Project (2017ZX09301018) and Key Technologies R & D Program of China Academy of Chinese Medical Sciences (CI2021A03808).Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-12T10:59:18.105500+00:00
DOI: 10.1038/s41540-021-00206-5 · PMC8632989